/ CompletedNot Applicable 硫辛酸片随机、开放、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, crossover design formal bioequivalence trial of lipoic acid tablets in Chinese healthy subjects
主要研究目的:以苏州富士莱医药股份有限公司的硫辛酸片为受试制剂;并以MEDA Pharma GmbH & Co. KG的硫辛酸片为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] The main purpose of the study was to evaluate the relative bioavailability and bioequivalence of lipoic acid tablets produced by Suzhou Fujilai Pharmaceutical Co., Ltd. as the test preparation and lipoic acid tablets produced by MEDA Pharma GmbH & Co. KG as the reference preparation.
/ CompletedNot Applicable 硫辛酸片随机、开放、交叉设计在中国健康受试者中的生物等效性正式试验
[Translation] A randomized, open-label, crossover design formal bioequivalence trial of lipoic acid tablets in Chinese healthy subjects
主要目的:以苏州富士莱医药股份有限公司的硫辛酸片为受试制剂;并以MEDA Pharma GmbH & Co. KG的硫辛酸片为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] Main objective: To evaluate the relative bioavailability and bioequivalence of lipoic acid tablets produced by Suzhou Fujilai Pharmaceutical Co., Ltd. as the test preparation and lipoic acid tablets produced by MEDA Pharma GmbH & Co. KG as the reference preparation.
100 Clinical Results associated with Suzhou Fushilai Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Suzhou Fushilai Pharmaceutical Co., Ltd.
100 Deals associated with Suzhou Fushilai Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Suzhou Fushilai Pharmaceutical Co., Ltd.